223 related articles for article (PubMed ID: 21371510)
1. Improving the reach of vaccines to low-resource regions, with a needle-free vaccine delivery device and long-term thermostabilization.
Chen X; Fernando GJ; Crichton ML; Flaim C; Yukiko SR; Fairmaid EJ; Corbett HJ; Primiero CA; Ansaldo AB; Frazer IH; Brown LE; Kendall MA
J Control Release; 2011 Jun; 152(3):349-55. PubMed ID: 21371510
[TBL] [Abstract][Full Text] [Related]
2. Dry-coated microprojection array patches for targeted delivery of immunotherapeutics to the skin.
Chen X; Prow TW; Crichton ML; Jenkins DW; Roberts MS; Frazer IH; Fernando GJ; Kendall MA
J Control Release; 2009 Nov; 139(3):212-20. PubMed ID: 19577597
[TBL] [Abstract][Full Text] [Related]
3. Nanopatch targeted delivery of both antigen and adjuvant to skin synergistically drives enhanced antibody responses.
Fernando GJ; Chen X; Primiero CA; Yukiko SR; Fairmaid EJ; Corbett HJ; Frazer IH; Brown LE; Kendall MA
J Control Release; 2012 Apr; 159(2):215-21. PubMed ID: 22306334
[TBL] [Abstract][Full Text] [Related]
4. Rapid kinetics to peak serum antibodies is achieved following influenza vaccination by dry-coated densely packed microprojections to skin.
Chen X; Fernando GJ; Raphael AP; Yukiko SR; Fairmaid EJ; Primiero CA; Frazer IH; Brown LE; Kendall MA
J Control Release; 2012 Feb; 158(1):78-84. PubMed ID: 22063004
[TBL] [Abstract][Full Text] [Related]
5. Needle-free vaccine delivery.
Giudice EL; Campbell JD
Adv Drug Deliv Rev; 2006 Apr; 58(1):68-89. PubMed ID: 16564111
[TBL] [Abstract][Full Text] [Related]
6. Improved DNA vaccination by skin-targeted delivery using dry-coated densely-packed microprojection arrays.
Chen X; Kask AS; Crichton ML; McNeilly C; Yukiko S; Dong L; Marshak JO; Jarrahian C; Fernando GJ; Chen D; Koelle DM; Kendall MA
J Control Release; 2010 Dec; 148(3):327-33. PubMed ID: 20850487
[TBL] [Abstract][Full Text] [Related]
7. Influenza subunit vaccine coated microneedle patches elicit comparable immune responses to intramuscular injection in guinea pigs.
Kommareddy S; Baudner BC; Bonificio A; Gallorini S; Palladino G; Determan AS; Dohmeier DM; Kroells KD; Sternjohn JR; Singh M; Dormitzer PR; Hansen KJ; O'Hagan DT
Vaccine; 2013 Jul; 31(34):3435-41. PubMed ID: 23398932
[TBL] [Abstract][Full Text] [Related]
8. Induction of potent CD8⁺ T cell responses through the delivery of subunit protein vaccines to skin antigen-presenting cells using densely packed microprojection arrays.
Ng HI; Fernando GJ; Kendall MA
J Control Release; 2012 Sep; 162(3):477-84. PubMed ID: 22841796
[TBL] [Abstract][Full Text] [Related]
9. Improving the reach of vaccines to low-resource regions with a needle-free vaccine delivery device and long-term thermostabilization.
Park K
J Control Release; 2011 Jun; 152(3):329. PubMed ID: 21600940
[No Abstract] [Full Text] [Related]
10. Epidermal delivery of protein and DNA vaccines.
Dean HJ
Expert Opin Drug Deliv; 2005 Mar; 2(2):227-36. PubMed ID: 16296750
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults.
Van Damme P; Oosterhuis-Kafeja F; Van der Wielen M; Almagor Y; Sharon O; Levin Y
Vaccine; 2009 Jan; 27(3):454-9. PubMed ID: 19022318
[TBL] [Abstract][Full Text] [Related]
12. Clinical experience with inactivated, virosomal influenza vaccine.
de Bruijn IA; Nauta J; Cramer WC; Gerez L; Palache AM
Vaccine; 2005 Jul; 23 Suppl 1():S39-49. PubMed ID: 16005120
[TBL] [Abstract][Full Text] [Related]
13. CAF01 liposomes as a mucosal vaccine adjuvant: In vitro and in vivo investigations.
Christensen D; Foged C; Rosenkrands I; Lundberg CV; Andersen P; Agger EM; Nielsen HM
Int J Pharm; 2010 May; 390(1):19-24. PubMed ID: 19879346
[TBL] [Abstract][Full Text] [Related]
14. Stability of influenza vaccine coated onto microneedles.
Choi HJ; Yoo DG; Bondy BJ; Quan FS; Compans RW; Kang SM; Prausnitz MR
Biomaterials; 2012 May; 33(14):3756-69. PubMed ID: 22361098
[TBL] [Abstract][Full Text] [Related]
15. Transcutaneous immunization with Intercell's vaccine delivery system.
Seid RC; Look JL; Ruiz C; Frolov V; Flyer D; Schafer J; Ellingsworth L
Vaccine; 2012 Jun; 30(29):4349-54. PubMed ID: 22682290
[TBL] [Abstract][Full Text] [Related]
16. The effect of strain rate on the precision of penetration of short densely-packed microprojection array patches coated with vaccine.
Crichton ML; Ansaldo A; Chen X; Prow TW; Fernando GJ; Kendall MA
Biomaterials; 2010 Jun; 31(16):4562-72. PubMed ID: 20226519
[TBL] [Abstract][Full Text] [Related]
17. Macroflux microprojection array patch technology: a new and efficient approach for intracutaneous immunization.
Matriano JA; Cormier M; Johnson J; Young WA; Buttery M; Nyam K; Daddona PE
Pharm Res; 2002 Jan; 19(1):63-70. PubMed ID: 11837701
[TBL] [Abstract][Full Text] [Related]
18. Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model.
Hagenaars N; Mastrobattista E; Glansbeek H; Heldens J; van den Bosch H; Schijns V; Betbeder D; Vromans H; Jiskoot W
Vaccine; 2008 Dec; 26(51):6555-63. PubMed ID: 18848856
[TBL] [Abstract][Full Text] [Related]
19. Targeted, needle-free vaccinations in skin using multilayered, densely-packed dissolving microprojection arrays.
Raphael AP; Prow TW; Crichton ML; Chen X; Fernando GJ; Kendall MA
Small; 2010 Aug; 6(16):1785-93. PubMed ID: 20665628
[TBL] [Abstract][Full Text] [Related]
20. Dose ranging of adjuvant and antigen in a cell culture H5N1 influenza vaccine: safety and immunogenicity of a phase 1/2 clinical trial.
Keitel W; Groth N; Lattanzi M; Praus M; Hilbert AK; Borkowski A; Tsai TF
Vaccine; 2010 Jan; 28(3):840-8. PubMed ID: 19835829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
